Compositions and methods for treating lysosomal disorders

Details for Australian Patent Application No. 2008334094 (hide)

Owner The Hospital for Sick Children Neuraltus Pharmaceuticals, Inc.

Inventors McGrath, Michael S.; Azhir, Arasteh Ari; Lingwood, Clifford A.

Agent Shelston IP

Pub. Number AU-A-2008334094

PCT Pub. Number WO2009/073564

Priority 61/095,825 10.09.08 US; 60/991,136 29.11.07 US

Filing date 26 November 2008

Wipo publication date 11 June 2009

International Classifications

A61K 31/41 (2006.01) - having five-membered rings with two or more ring hetero atoms, at least one of which is nitrogen, e.g. tetrazole

Event Publications

17 June 2010 PCT application entered the National Phase

  PCT publication WO2009/073564 Priority application(s): WO2009/073564

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008334095-Gene expression markers for inflammatory bowel disease

2008334090-Industrial production of organic compounds using recombinant organisms expressing methyl halide transferase